E-LIB Suche - Ergebnisse für: Cannita, K.

1

First-line carboplatin/nab-paclitaxel in advanced ovarian c..:

Parisi, A. ; Palluzzi, E. ; Cortellini, A....
Clinical and Translational Oncology. 22 (2019) 1 - p. 158-162 , 2019

Link: https://doi.org/10.1007/..

2

Psychological impact of clinical treatment after breast can..:

Di Giacomo, D. ; Ranieri, J. ; Perilli, E....
Neurology, Psychiatry and Brain Research. 32 (2019) - p. 85-90 , 2019

Link: https://doi.org/10.1016/..

3

Emotional "Patient-Oriented" Support in Young Patients With..:

Di Giacomo, D. ; Ranieri, J. ; Donatucci, E....
Frontiers in Psychology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

4

P218 Primary dose-dense epirubicin/cyclophosphamide→docetax..:

Cocciolone, V. ; Cannita, K. ; Bruera, G....
The Breast. 24 (2015) - p. S100-S101 , 2015

Link: https://doi.org/10.1016/..

5

P043 Bevacizumab/paclitaxel as first line therapy for metas..:

Cannita, K. ; Paradisi, S. ; Cocciolone, V....
The Breast. 24 (2015) - p. S41 , 2015

Link: https://doi.org/10.1016/..

6

Bioclinical Parameters Driving Decision-Making of Subsequen..:

Irelli, A. ; Bruera, G. ; Cannita, K....
BioMed Research International. 2014 (2014) - p. 1-7 , 2014

Link: https://doi.org/10.1155/..

7

Type 2 diabetes mellitus and efficacy outcomes from imune c..:

Cortellini A ; D'Alessio A ; Cleary S...
info:eu-repo/semantics/altIdentifier/wos/WOS:001043737000001. , 2023

Link: https://hdl.handle.net/1..

8

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

9

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

10

Differential influence of antibiotic therapy and other medi..:

Cortellini A ; Di Maio M ; Nigro O...
info:eu-repo/semantics/altIdentifier/pmid/33827906. , 2021

Link: http://hdl.handle.net/23..

11

PANHER study: a 20-year treatment outcome analysis from a m..:

Pizzuti L ; Krasniqi E ; Sperduti I...
info:eu-repo/semantics/altIdentifier/pmid/35173816. , 2021

Link: http://hdl.handle.net/11..

12

Smoking status during first‐line immunotherapy and chemothe..:

Cortellini A ; De Giglio A ; Cannita K...
info:eu-repo/semantics/altIdentifier/pmid/33527756. , 2021

Link: http://hdl.handle.net/11..

13

Predictive ability of a drug-based score in patients with a..:

Buti S ; Bersanelli M ; Perrone F...
info:eu-repo/semantics/altIdentifier/wos/WOS:000655598300025. , 2021

Link: http://hdl.handle.net/11..

14

Predictive ability of a drug-based score in patients with a..:

Buti S ; Bersanelli M ; Perrone F...
info:eu-repo/semantics/altIdentifier/pmid/33934059. , 2021

Link: http://hdl.handle.net/23..

15

Smoking status during first-line immunotherapy and chemothe..:

Cortellini A ; De Giglio A ; Cannita K...
info:eu-repo/semantics/altIdentifier/pmid/33527756. , 2021

Link: https://hdl.handle.net/1..